Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Geoffrey Owen Littlejohn

17PUBLICATIONS

15CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityOrthopticsClinical pharmacology and therapeuticsRheumatology and arthritis

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (17)

Sort by Publication Date:

|Sep 13, 2025

Correction: Real‑World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis.

Peter Youssef, Sabina Ciciriello, Talib Tahir

|Feb 26, 2025

Neuroinflammatory and Immunological Aspects of Fibromyalgia.

Kate Findeisen, Emma Guymer, Geoffrey Littlejohn

|Feb 05, 2025

The Relationship Between Patient-Reported Quality of Life and Physician-Derived Clinical Outcomes in Rheumatoid Arthritis in the Australian OPAL Dataset.

Geoffrey Littlejohn, Nithila Anbumurali, Catherine O'Sullivan

|Jan 05, 2025

Real-World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis.

Peter Youssef, Sabina Ciciriello, Talib Tahir

|Apr 18, 2024

Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022.

Geoffrey Littlejohn, Nithila Anbumurali, Catherine O'Sullivan

|Mar 08, 2024

Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia.

Geoffrey Littlejohn, Joanna Leadbetter, Belinda E Butcher

Pageof 3

Frequent Collaborators

7 joint publications

Tegan Smith

7 joint publications

Catherine O'Sullivan

5 joint publications

Paul Bird

5 joint publications

Hedley Griffiths

4 joint publications

Belinda E Butcher

4 joint publications

Emma Guymer

2 joint publications

Kathleen Tymms

2 joint publications

Peter Youssef

2 joint publications

Claire T Deakin

1 joint publications

Lynden Roberts

Frequent Collaborators

7 joint publications

Tegan Smith

7 joint publications

Catherine O'Sullivan

5 joint publications

Paul Bird

5 joint publications

Hedley Griffiths

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on : Jan 05, 2024

Measuring Psoriasis Severity at Home

Measuring Psoriasis Severity at Home

Published on : Mar 01, 2024

See more related videos

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on : Jan 05, 2024

Measuring Psoriasis Severity at Home

Measuring Psoriasis Severity at Home

Published on : Mar 01, 2024

See more related videos